Literature DB >> 19076062

High-density lipoproteins, inflammation and oxidative stress.

Fatiha Tabet1, Kerry-Anne Rye.   

Abstract

Plasma levels of HDL (high-density lipoprotein)-cholesterol are strongly and inversely correlated with atherosclerotic cardiovascular disease. Both clinical and epidemiological studies have reported an inverse and independent association between serum HDL-cholesterol levels and CHD (coronary heart disease) risk. The cardioprotective effects of HDLs have been attributed to several mechanisms, including their involvement in the reverse cholesterol transport pathway. HDLs also have antioxidant, anti-inflammatory and antithrombotic properties and promote endothelial repair, all of which are likely to contribute to their ability to prevent CHD. The first part of this review summarizes what is known about the origins and metabolism of HDL. We then focus on the anti-inflammatory and antioxidant properties of HDL and discuss why these characteristics are cardioprotective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19076062     DOI: 10.1042/CS20080106

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  57 in total

1.  Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins.

Authors:  Jens O Lagerstedt; Giorgio Cavigiolio; Madhu S Budamagunta; Ioanna Pagani; John C Voss; Michael N Oda
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 2.  HDL--is it too big to fail?

Authors:  Dominic S Ng; Norman C W Wong; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2013-01-15       Impact factor: 43.330

Review 3.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport.

Authors:  George H Rothblat; Michael C Phillips
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

4.  High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

Authors:  Jason Baker; Woubeshet Ayenew; Harrison Quick; Katherine Huppler Hullsiek; Russell Tracy; Keith Henry; Daniel Duprez; James D Neaton
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

5.  The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.

Authors:  Fatiha Tabet; Alan T Remaley; Aude I Segaliny; Jonathan Millet; Ling Yan; Shirley Nakhla; Philip J Barter; Kerry-Anne Rye; Gilles Lambert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-03       Impact factor: 8.311

6.  Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

Authors:  Daniel A Duprez; Lewis H Kuller; Russell Tracy; James Otvos; David A Cooper; Jennifer Hoy; Jacqueline Neuhaus; Nicholas I Paton; Nina Friis-Moller; Fiona Lampe; Angelike P Liappis; James D Neaton
Journal:  Atherosclerosis       Date:  2009-05-13       Impact factor: 5.162

7.  Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey.

Authors:  Man-huei Chang; Ajay Yesupriya; Renée M Ned; Patricia W Mueller; Nicole F Dowling
Journal:  BMC Med Genet       Date:  2010-04-20       Impact factor: 2.103

Review 8.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

Review 9.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.

Authors:  Fatiha Tabet; Kasey C Vickers; Luisa F Cuesta Torres; Carrie B Wiese; Bassem M Shoucri; Gilles Lambert; Claire Catherinet; Leonel Prado-Lourenco; Michael G Levin; Seth Thacker; Praveen Sethupathy; Philip J Barter; Alan T Remaley; Kerry-Anne Rye
Journal:  Nat Commun       Date:  2014-02-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.